📊 In partnership with @JaebCenter, a multicenter trial found the SteadiSet™ insulin infusion set achieved a 95% 7-day survival rate, offering a reliable extended-wear option for adults with #Type1Diabetes. 🔗 . #DiabetesTech #DiabetesResearch

Congrats to GCDTR member Dr. Tabia H. Akintobi of @MSMedSchool for being named to the @theNASEM Standing Committee on Advancing Science Communication!. Her voice in public health and community-engaged research continues to shape national conversations.

Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.

RT @egdrc: 📊Dr. Temiloluwa Prioleau is transforming diabetes care with DiaTrend—a powerful dataset advancing personalized, tech-enabled tre….

A pilot study by @HallerMichael & GCDTR members, involving 74 adults across 33 FQHCs, found that support coaches with lived diabetes experience significantly reduced diabetes distress and nearly doubled continuous glucose monitor usage. Read more:

📲 Smart insulin + CGM = better outcomes. A new study shows the Bigfoot Unity system improves blood sugar control and reduces diabetes distress in people with type 2 diabetes. 🔗 #DiabetesTech #Type2Diabetes #CGM

New study led by members of GCDTR at @ufdiabetes shows Project ECHO Diabetes cut costs by improving glycemic control. A scalable model for better, cheaper diabetes care. #DiabetesCare #Telemedicine #PublicHealth

RT @ufdiabetes: A new grant from the American Diabetes Association's Innovative Translational Clinical Science program was awarded to Dr. A….

RT @egdrc: Honored today at #ADA2025, @kmvnarayan14 received the Distinguished Int’l Service Award for his global impact on diabetes. Durin….

RT @egdrc: EGDRC & @GCDTR always show up for #ADA Scientific Sessions in numbers—and this year is no different! 💪 Catch our researchers’ wo….

RT @egdrc: The #CopenhagenDeclaration, Supported by @novonordiskfond and led by #EGDRC offers a bold new global framework to expand access,….

📢 New in Diabetes Care: CGM metrics moderately correlate w/ stimulated C-peptide in youth w/ new-onset T1D, but not strong enough to replace C-peptide in trials. Co-author: GCDTR's Roy W. Beck (@JaebCenter)🔗 #T1D #CGM #DiabetesResearch #DiabetesCare.

RT @egdrc: 📢 A new Emory-led study published in @TheLancetEndo by Dr.Guillermo Umpierrez & Dr. Thaer Idrees explores the evolution of fixed….

RT @egdrc: 📈 New Emory-led study links higher arterial stiffness (pulse wave velocity) to increased odds of #Alzheimers biomarker positivit….

🆕 A must-read in Preventing Chronic Disease:.“Harnessing the Power of #CommunityEngagement for Population Health” by GCDTR member Tabia Henry Akintobi (@MSMEDU) spotlights trust & community-led public health. @pcdjournal

RT @egdrc: Dr. Carl Yang is using AI to personalize #diabetes care. His TACCO #algorithm clusters patients by shared risk factors—clinical,….

RT @egdrc: 📢 New study: Sexual minority couples show high concordance in hypertension & overweight/obesity — especially among male couples.….

RT @egdrc: "Facts alone don’t change minds—but connection can.". EGDRC Director, @kmvnarayan14 shares how humility, dialogue, and storytell….

RT @egdrc: With this year’s numbers still rolling in, we’re celebrating a big win from last year: 1,343 publications! 🎉 Huge kudos to the e….

RT @egdrc: New study in Diabetes Care co-authored by EGDRC's Dr. Guillermo Umpierrez finds ~24% of people with difficult-to-control type 2….

📢 New findings from the INHALE-3 Extension Study! Inhaled technosphere insulin (TI) + insulin degludec sustained improved HbA1c levels over 30 weeks in adults with type 1 diabetes. 42% reached A1C <7.0% by week 30! 🔗